Grace Therapeutics, Inc. - GRCE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$21.73M
QoQ value delta ($000)
+$6.744M (+44.99%)
Implied price effect (QoQ)
+30.69%
Shares
Total shares
4,801,273
QoQ shares delta
+473,636 (+10.94%)
Total shares held by funds (by quarter)

Market chart (GRCE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 35 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Cerity Partners LLC 3,931 849,055 0.01%
Eversept Partners, LP 3,503 756,600 0.18%
Nantahala Capital Management, LLC 3,371 728,203 0.12%
BANK OF AMERICA CORP /DE/ 2,290 494,723 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 1,859 401,656 0.0%
VANGUARD GROUP INC 1,479 423,981 0.0%
RENAISSANCE TECHNOLOGIES LLC 1,129 243,910 0.0%
JANE STREET GROUP, LLC 773 167,097 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 522 112,800 0.0%
CITADEL ADVISORS LLC 457 98,742 0.0%
MARSHALL WACE, LLP 423 91,416 0.0%
Connective Capital Management, LLC 391 84,549 0.32%
Quadrature Capital Ltd 309 66,822 0.0%
XTX Topco Ltd 292 63,094 0.01%
Birchview Capital, LP 231 50,000 0.13%
Diametric Capital, LP 184 39,796 0.05%
Pale Fire Capital SE 174 37,762 0.02%
UBS Group AG 121 26,301 0.0%
KESTRA PRIVATE WEALTH SERVICES, LLC 60 13,000 0.0%
OPPENHEIMER & CO INC 46 10,000 0.0%
PRELUDE CAPITAL MANAGEMENT, LLC 46 10,074 0.0%
VANGUARD FIDUCIARY TRUST CO 40 8,750 0.0%
BNP PARIBAS FINANCIAL MARKETS 32 7,100 0.0%
GROUP ONE TRADING LLC 23 5,000 0.0%
MORGAN STANLEY 21 4,548 0.0%